ABVC Biopharma Files 8-K Report
Ticker: ABVC · Form: 8-K · Filed: Sep 10, 2024 · CIK: 1173313
| Field | Detail |
|---|---|
| Company | Abvc Biopharma, Inc. (ABVC) |
| Form Type | 8-K |
| Filed Date | Sep 10, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, 8-k
TL;DR
ABVC filed an 8-K on 9/10/24, just a routine update.
AI Summary
On September 10, 2024, ABVC Biopharma, Inc. filed an 8-K report detailing other events. The company, incorporated in Nevada, is based in Fremont, California, and operates in the pharmaceutical preparations sector. This filing does not contain specific financial transactions or material agreements.
Why It Matters
This filing indicates that ABVC Biopharma has made a regulatory submission, which could be a precursor to future announcements or updates regarding their business operations.
Risk Assessment
Risk Level: low — The filing is a standard 8-K report of other events and does not disclose any new material risks or significant financial changes.
Key Players & Entities
- ABVC BIOPHARMA, INC. (company) — Registrant
- September 10, 2024 (date) — Date of earliest event reported
- Nevada (jurisdiction) — State of incorporation
- Fremont, CA (location) — Principal executive offices
- 26-0014658 (identifier) — IRS Employer Identification No.
FAQ
What is the primary purpose of this 8-K filing for ABVC Biopharma, Inc.?
The primary purpose of this 8-K filing is to report 'Other Events' as of September 10, 2024.
When was the earliest event reported in this filing?
The earliest event reported in this filing occurred on September 10, 2024.
In which U.S. state is ABVC Biopharma, Inc. incorporated?
ABVC Biopharma, Inc. is incorporated in Nevada.
What is the business address of ABVC Biopharma, Inc.?
The business address of ABVC Biopharma, Inc. is 44370 Old Warm Springs Blvd., Fremont, CA 94538.
What is the Standard Industrial Classification (SIC) code for ABVC Biopharma, Inc.?
The Standard Industrial Classification (SIC) code for ABVC Biopharma, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Stats: 416 words · 2 min read · ~1 pages · Grade level 13 · Accepted 2024-09-10 16:01:26
Key Financial Figures
- $0.001 — ch registered Common Stock, par value $0.001 per share ABVC The Nasdaq Stock Mar
Filing Documents
- ea0214114-8k_abvcbio.htm (8-K) — 24KB
- 0001213900-24-077361.txt ( ) — 190KB
- abvc-20240910.xsd (EX-101.SCH) — 3KB
- abvc-20240910_lab.xml (EX-101.LAB) — 33KB
- abvc-20240910_pre.xml (EX-101.PRE) — 22KB
- ea0214114-8k_abvcbio_htm.xml (XML) — 3KB
01 Other Events
Item 8.01 Other Events. On September 6, 2024, ABVC Biopharma, Inc. (the " Company ") received a written notification from the Nasdaq Stock Market Listing Qualifications Staff, indicating that the Company has regained compliance with Listing Rules 5635(a)(1) and 5635(a)(2) (the " Shareholder Approval Rules ") for continued listing on The Nasdaq Capital Market pursuant to the Board Resolution dated May 16, 2024. 1 SIGNATURE Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ABVC BioPharma, Inc. September 10, 2024 By: /s/ Uttam Patil Uttam Patil Chief Executive Officer 2